SXTC Reports $0 Revenue, $0 EPS, No Deals, No Growth Metrics
China SXT Pharmaceuticals, Inc. Class A Ordinary Shares · Now $1.67
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS